Aurora Cannabis and Tilray to Supply Experimental French Medical Cannabis Program

Aurora Cannabis (NYSE: ACB) and Tilray (NASDAQ: TLRY) were among a handful of international marijuana producers chosen to participate in a new French medical marijuana experiment. The National Agency for Medicines and Health Products Safety (ANSM) is trialing a small-scale, 18- to 24-month program to supply patients with medical marijuana free of charge. Partnering with a France-based pharmaceutical establishment, producers will supply up to 3,000 patients with free product while complying with pharmaceutical standards, including Good Manufacturing Practices (GMP).